Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Clozapine eligibility among state hospital patients.

Essock SM, Hargreaves WA, Dohm FA, Goethe J, Carver L, Hipshman L.

Schizophr Bull. 1996;22(1):15-25.

2.

Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals.

Essock SM, Frisman LK, Covell NH, Hargreaves WA.

Arch Gen Psychiatry. 2000 Oct;57(10):987-94.

PMID:
11015817
3.
4.

Clozapine eligibility: the effect of stringent criteria on ethnic, gender and age subgroups of schizophrenic patients.

Juarez-Reyes MG, Shumway M, Battle C, Bacchetti P, Hansen MS, Hargreaves WA.

Prog Neuropsychopharmacol Biol Psychiatry. 1996 Nov;20(8):1341-52.

PMID:
9004341
5.

Clozapine for refractory schizophrenia: the Illinois experience.

Buckman RW, Malan RD.

J Clin Psychiatry. 1999;60 Suppl 1:18-22; discussion 28-30.

6.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

7.

Savings in hospital bed-days related to treatment with clozapine.

Reid WH, Mason M, Toprac M.

Hosp Community Psychiatry. 1994 Mar;45(3):261-4.

PMID:
8188199
8.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
9.

Clozapine's effectiveness for patients in state hospitals: results from a randomized trial.

Essock SM, Hargreaves WA, Covell NH, Goethe J.

Psychopharmacol Bull. 1996;32(4):683-97.

PMID:
8993092
10.

New vs. old antipsychotics: the Texas experience.

Reid WH.

J Clin Psychiatry. 1999;60 Suppl 1:23-5; discussion 28-30.

11.

Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

Rosenheck R, Cramer J, Allan E, Erdos J, Frisman LK, Xu W, Thomas J, Henderson W, Charney D.

Arch Gen Psychiatry. 1999 Jun;56(6):565-72.

PMID:
10359474
12.

Treatment-resistant schizophrenia--the role of clozapine.

Meltzer HY.

Curr Med Res Opin. 1997;14(1):1-20. Review.

PMID:
9524789
13.

[Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].

Bret P, Jolivel C, Bret MC, Veylit S, Martin C, Garcia P.

Encephale. 1998 Jul-Aug;24(4):365-77. French.

PMID:
9809242
14.

Clinical effects of a randomized switch of patients from clozaril to generic clozapine.

Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K.

J Clin Psychiatry. 2001;62 Suppl 5:14-7; discussion 23-4.

15.
16.

[Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].

Geronimi-Ferret D, Lesay M, Barges-Bertocchio MH, Cornet-Bonnefont M, Robert H.

Encephale. 1997 Sep;23 Spec No 4:24-31. French.

PMID:
9417402
17.

Seizures associated with clozapine treatment in a state hospital.

Wilson WH, Claussen AM.

J Clin Psychiatry. 1994 May;55(5):184-8.

PMID:
8071267
19.

[Ten years of clinical experience with clozapine about 170 patients].

Levoyer D, Martinet JP, Badiche A, Millet B.

Encephale. 2004 May-Jun;30(3):285-95. French.

PMID:
15235527
20.

[Long-term clinical experience with clozapine].

Gelly F, Chambon O, Marie-Cardine M.

Encephale. 1997 Sep-Oct;23(5):385-96. French.

PMID:
9453932
Items per page

Supplemental Content

Write to the Help Desk